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1. Introduction 
Oxidative stress plays a critical role in the pathogenesis of inflammation (Winrow et al., 
1993), which is a physiological response that protects the body from stimuli including 
infections and tissue injury. The magnitude of the inflammatory response is crucial, and 
insufficient responses result in immunodeficiency, which can lead to infection and cancer. 
Excessive responses cause morbidity and mortality from diseases such as rheumatoid 
arthritis, Crohn’s disease, atherosclerosis, diabetes, Alzheimer’s disease, multiple sclerosis, 
and cerebral and myocardial ischemia (Tracey, 2002). Inflammation is associated with a 
wide range of inflammatory mediators that initiate inflammatory responses, recruit and 
activate other cells to the site of inflammation, and subsequently resolve the inflammation 
(Gallin & Snyderman, 1999). The expression of pro-inflammatory mediators such as 
cytokines, chemokines, adhesion molecules, iNOS, and COX-2 involves nuclear factor-κB 
(NF-κB) (Baeuerle & Baltimore, 1996; Hayden & Ghosh, 2004). Mitogen-activated protein 
kinases (MAPKs) pathways are also reportedly stimulated by inflammatory mediators 
(Guha & Mackman, 2001). 
The genus Sasa (Poaceae) is composed of perennial plants commonly known as bamboo 
grasses, and various Sasa species are widely distributed in Asian countries including China, 
Japan, Korea, and Russia (Okabe et al., 1975). Sasa leaves have been used in traditional 
medicine for their anti-inflammatory, antipyretic, and diuretic properties (Bae, 2000). 
Bamboo leaves have also been used in clinical settings to treat hypertension, cardiovascular 
disease, and cancer (Shibata et al., 1975).  
Many recent studies have described the beneficial health effects of Sasa species leaves, which 
have been used as alternative medicines. S. albomarginata extract reportedly has anticancer 
properties (Shibata et al., 1979). Both lignin and polysaccharide preparation from Sasa 
species reportedly have antitumor properties (Suzuki et al., 1968; Yamafuji & Murakami, 
1968). Two polysaccharide preparations (GK1 and GK2) from S. kurilensis was found to 
negatively affect the growth of Sarcoma-180 implanted in mice (Raidaru et al., 1997). Also, 
Sasa Health, an alkaline extract derived from S. senanensis leaves containing 
polysaccharides, chlorophyllin, lignin, and flavonoids, reportedly has a protective effect on 
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spontaneous mammary tumorigenesis (Tsunoda et al., 1998) and Her2/NeuN mammary 
tumorigenesis (Ren et al., 2004). Researchers have also recently reported that S. senanensis 
leaf extracts have antioxidant and immunostimulation-mediated antitumor properties 
(Kurokawa et al., 2006; Seki et al., 2008). Hagasewa et al. (2008) reported antioxidant C-
glycosyl flavones in the leaves of S. kurilensis var. gigantea. Extract from S. borealis leaves 
reportedly improves chronic high glucose-induced endothelial apoptosis (Choi et al., 2008), 
as well as insulin resistance by modulating inflammatory cytokine secretion in high fat diet-
induced obese C57/BL6J mice (Yang et al., 2010). Park et al. (2007) reported four antioxidant 
flavone glycosides (tricine-7-O-ǃ-D-glucopyranoside, isoorientin, apigenin 6-C-ǃ-D-
xylopyranosyl-8-C-ǃ-D-glucopyranoside, isoorientin 2-O-ǂ-L-rhamnoside) from S. borealis. 
Two phenolic compounds, (–)-syringaresinol and tricin, isolated from S. borealis, exhibited 
P-glycoprotein inhibitory properties in adrimiamycin-resistant human breast cancer, MCF-
7/ARD (Jeong et al., 2007).  
S. quelpaertensis Nakai is another bamboo grass. It is a native Korean plant that grows only 
on Mt. Halla on Jeju Island, South Korea. This small bamboo grass has recently been the 
focus of much attention due to its potential biomass as well as its role as an invasive plant 
that inhibits the growth of other plants in the habitat on Jeju Island. Young leaves of S. 
quelpaertensis are used for a popular bamboo tea, but their beneficial health effects and the 
bioactive compounds contained in the plant have not yet been identified. Thus, systematic 
research about using its leaves as an industrial bio-resource is increasingly required. As a 
first step to evaluating the potential of S. quelpaertensis leaves as nutraceuticals, in this study, 
we investigated the anti-oxidative and anti-inflammatory activities of S.quelpaertensis leaf 
extract.  
2. Materials and methods 
2.1 Reagents 
Dulbecco's modified Eagle's medium (DMEM), fetal bovine serum (FBS), and penicillin–
streptomycin (PS) were obtained from Gibco-BRL (Grand Island, NY, USA). Antibody 
against inducible NOS (iNOS) was purchased from Calbiochem (San Diego, CA, USA), and 
antibody against cyclooxygenase-2 (COX-2) was obtained from Becton Dickinson (Mountain 
View, CA, USA). Anti-phospho-extracellular signal-regulated kinase (ERK1/2) was 
acquired from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Antibodies against 
ERK1/2, JNK1/2, phospho-JNK1/2, p38, and phospho-p38 were obtained from Cell 
Signaling Technology (Beverly, MA, USA). The lactate dehydrogenase (LDH) Cytotoxicity 
Detection Kit was purchased from Takara Shuzo Co. (Otsu, Shiga, Japan). Protein assay 
reagent was purchased from Bio-Rad Laboratories Inc. (Hercules, CA, USA). Trizol reagent 
was purchased from Molecular Research Center Inc. (Cincinnati, OH, USA), 
lipopolysaccharide (LPS) (Escherichia coli 026:B6) and 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl tetrazolium bromide (MTT) were purchased from Sigma (St. Louis, MO, USA). All 
other reagents were acquired from Sigma. 
2.2 Preparation of extracts  
S. quelpaertensis leaves were collected in October 2010, from Mt. Halla on Jeju Island, South 
Korea. A dried powder of the S. quelpaertensis leaves was extracted using 80% methanol 
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(MeOH) at room temperature for 48 h. This procedure was repeated twice. The combined 
extract was concentrated on a rotary evaporator under reduced pressure and freeze-dried to 
a powder. The dried extract was dissolved in water and then fractionated using the organic 
solvents n-hexane (hexane), ethyl acetate (EtOAc), and n-butanol (BuOH) at room 
temperature. Each fraction was concentrated on a rotary evaporator under reduced pressure 
and freeze-dried to a powder. 
2.3 Measurement of antioxidant activities 
2.3.1 DPPH radical scavenging assay 
2,2-Diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity was examined according 
to the method reported by Tateyama et al. (1997) with slight modifications. Briefly, the 
extracts were mixed with methanol and then added to 0.4 mM DPPH in methanol. After 20 
min of incubation in the dark at room temperature, the reduction in the DPPH free radical 
was measured by absorbance, which was read using a microplate reader (Bio-Tek 
Instruments, Winooski, VT, USA) at 517 nm. Trolox and BHA, a stable antioxidant, were 
used as a reference control and pure methanol was used as a control sample. Three 
replicates were made for each test sample. The radical scavenging activity of samples, 
expressed as percent inhibition, was calculated according to the follow formula: % inhibition 
= (A0/AX)/A0  100, where A0 and AX are the absorbance values of the blank sample and 
the tested samples, respectively. The results were indicated as IC50, which is the 50% 
inhibitory concentration of DPPH radical scavenging activity. 
2.3.2 NO scavenging activity 
Nitric oxide (NO) scavenging activity was measured using the method described by Feelisch 
and Stamler (1996) with slight modifications. Sodium nitroprusside (SNP) in an aqueous 
solution at physiological pH spontaneously generates nitric oxide, which can be measured 
using the Griess reagent system. The reaction solution containing 1 mM SNP in phosphate-
buffered saline (PBS) (pH 7.4) was mixed with the extract, followed by incubation at room 
temperature for 3 h. Then, the reaction solution was mixed with an equal volume of Griess 
reagent (1% sulfanilamide and 0.1% naphthylethylenediamine in 5% phosphoric acid). The 
absorbance at 540 nm was recorded using a microplate reader. The percentage of NO 
scavenging was measured through comparison with the absorbance values of the blank 
sample. 
2.3.3 Superoxide radical scavenging assay 
Superoxide (O2–) was generated using the enzymatic method. Briefly, the extracts were 
mixed with an equal volume of reaction reagent [2 mM Na2 EDTA in phosphate buffer (50 
mM KH2PO4/KOH, pH 7.4), 0.05 mM nitroblue tetrazolium chloride (NBT) in a buffer, and 
1 mM hypoxanthine in 50 mM KOH]. The reaction was started by adding xanthine oxidase 
(XOD) in a buffer to the mixture (final XOD concentration was 0.05 U/ml). After 1 h of 
incubation at room temperature, scavenging activity was measured by absorbance, which 
was read using a microplate reader at 560 nm. Trolox and BHA, a stable antioxidant, were 
used as a reference control; SOD and allopurinol were used as a positive control. The NBT 
reduction (%) was calculated according to the following formula: % inhibition = 
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(A0/AX)/A0  100, where A0 and AX are the absorbance values of the blank sample and the 
tested samples, respectively.  
2.3.4 Determination of XOD-inhibitory activity 
XOD-inhibitory activity was measured by detecting uric acid formation according to the 
method described by Puig et al. (1989) with slight modifications. First, the extracts and 
reaction reagent [2 mM Na2 EDTA in a phosphate buffer (50 mM KH2PO4/KOH, pH 7.4) 
and 1 mM hypoxanthine in 50 mM KOH] were mixed in a 96-well microplate. The reaction 
was started by adding XOD in a buffer to the mixture (final XOD concentration was 0.05 
U/ml). After 1 h of incubation at room temperature, uric acid production was measured by 
absorbance, which was read using a microplate reader at 295 nm. Trolox and BHA, a stable 
antioxidant, were used as a reference control. SOD and allopurinol were used as a positive 
control. Uric acid production was calculated according to the following formula: % 
inhibition = (A0/AX)/A0  100, where A0 and AX are the absorbance values of the blank 
sample and the tested samples, respectively.  
2.4 Cell culture  
The RAW 264.7 murine macrophage cell line was obtained from the Korea Cell Line Bank 
(Seoul, Korea). Cells were cultured in 1% PS/DMEM containing 10% heat-inactivated FBS at 
37°C in a 5% CO2 incubator.  
2.5 Cytotoxicity assay - MTT and LDH release assays 
Cell viability and cytotoxicity were determined using a 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) cell viability assay and lactic dehydrogenase (LDH) 
release assay. Cells were seeded at a density of 5 × 104 cells/well into a 96-well flat-bottom 
cell culture plate in the presence or absence of the extracts. Mitochondrial enzyme activity, 
which is an indirect measure of the number of viable respiring cells, was determined using 
an MTT reagent after 40 h of treatment with methanol extract or its fractions. Absorbance 
was read using a microplate reader (Bio-Tek Instruments) at 595 nm. The effect of extracts 
on cell viability was evaluated as the relative absorbance compared to that of control 
cultures. LDH leakage is known to be a marker of damage to the cell membrane, and the 
LDH level was detected using the culture supernatants according to the LDH cytotoxicity 
detection kit instructions (Takara Shuzo Co.). Cytotoxicity was expressed as the percentage 
of released LDH (LDH released into the medium/maximal LDH release  100). Maximal 
LDH release was measured after lysis of the cells with 0.5% Triton X-100. 
2.6 Measurement of NO and PGE2 production 
The amount of nitrite was determined using a colorimetric assay (Green et al., 1982). Briefly, 
100 μl of cell culture medium was mixed with an equal volume of Griess reagent (1% 
sulfanilamide and 0.1% naphthylethylenediamine in 5% phosphoric acid) and incubated at 
room temperature for 10 min. The absorbance at 540 nm was recorded using a microplate 
reader. Nitrite concentration was determined using extrapolation from a sodium nitrite 
standard curve. Concentration of prostaglandin E2 (PGE2) in the culture medium was 
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quantified by enzyme-linked immunosorbent assay (ELISA) according to the 
manufacturer’s instructions. 
2.7 Measurement of iNOS enzyme activity 
The activity of the iNOS enzyme in the cell lysate was measured as the L-arginine- and 
NADPH-dependent generation of nitrite. Briefly, 200 µg cell lysate was incubated for 180 
min at room temperature in 100 µl of a reaction buffer containing 20 mM sodium phosphate 
buffer, 2 mM NADPH, 2 mM L-arginine, and 10 µm FAD at pH 6.7. The reaction was 
stopped by adding 10 U/ml LDH and 10 mM pyruvate. Next, the reaction mixture was 
incubated with an equal volume of Griess reagent. The absorbance at 540 nm was recorded 
using a microplate reader. Nitrite concentration was determined by extrapolation from a 
sodium nitrite standard curve. 
2.8 Western blot analysis  
Cells were washed twice with ice-cold PBS and collected. The cells were then treated with a 
lysis buffer [1× RIPA (Upstate Cell Signaling Solutions, Lake Placid, NY, USA), 1 mM 
phenylmethylsulfonyl fluoride (PMSF), 1 mM Na3VO4, 1 mM NaF, 1 μg/ml aprotinin, 1 
μg/ml pepstatin, and 1 μg/ml leupeptin] and incubated on ice for 1 h. Cell debris was 
removed by centrifugation and then protein concentration was determined using a Bio-Rad 
protein assay reagent (Bio-Rad Laboratories, Hercules, CA, USA). Cell lysates were 
subjected to 7.5% or 10% SDS-polyacrylamide gel electrophoresis and transferred to 
polyvinylidene difluoride membranes. The membranes were blocked with a solution of 
0.1% Tween 20/Tris-buffed saline containing 5% nonfat milk powder for 1 h at room 
temperature. After incubation overnight at 4°C with the indicated primary antibody, the 
membranes were incubated with a horseradish peroxidase-conjugated secondary antibody 
for 1 h at room temperature. Immunodetection was carried out using an ECL Western 
blotting detection reagent. The signal intensity of relative bands was determined using 
image acquisition and analysis software (LabWorks, Cambridge, UK).  
2.9 RNA preparation and reverse transcription-polymerase chain reaction (RT-PCR) 
Total cellular RNA was isolated using a Trizol reagent (Molecular Research Center, 
Cincinnati, OH, USA) according to the manufacturer’s instructions. RNA concentration and 
purity were determined by measuring absorbance at 260 and 280 nm. A cDNA synthesis 
was performed using the ImProm-II™ Reverse Transcription System (Promega, Madison, 
WI, USA) with an oligo dT-15 primer, as recommended by the supplier. PCR analyses were 
then performed on aliquots of cDNA preparations using a thermal cycler. The reactions 
were carried out in a 25 l volume containing (final concentration) 1 unit of Taq DNA 
polymerase, 0.2 mM dNTP, 10 reaction buffer, and 100 pmol primers (Table 1). The cycle 
number was optimized to ensure product accumulation in the exponential range. -Actin 
was used as an internal control to normalize the RNA content of each sample. Amplification 
was initiated at 94°C for 5 min, followed by 18–27 cycles of denaturation at 94°C for 45 s, 
annealing at the appropriate primer-pair annealing temperature for 45 s, and extension at 
72°C for 1 min, followed by a final extension of 10 min at 72°C. After amplification, portions 
of the PCR reactions were electrophoresed on 2% agarose gel and visualized using ethidium 
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bromide staining and a UV transilluminator (SLB Mylmagger; UVP Inc., Upland, CA, USA). 
The signal intensity of relative bands was determined using image acquisition and analysis 
software (LabWorks).  
 







TNF- Forward 5’-TTGACCTCAGCGCTGAGTTG-3’ 
Reverse 5’-CCTGTAGCCCACGTCGTAGC-3’ 





-Actin Forward 5’-AGGCTGTGCTGTCCCTGTATGC-3’ 
Reverse 5’-ACCCAAGAAGGAAGGCTGGAAA-3 
Table 1. The sequences of primers used in RT-PCR analysis. 
2.10 Transient transfection and luciferase assay 
Cells were seeded at a density of 5 × 103 cells/well into a 96-well flat-bottom cell culture 
plate and cultured for 18 h. RAW 264.7 cells were transiently transfected with or without a 
NF-B-promoted luciferase reporter gene plasmid pNF-B-Luc (Promega) and a Renilla 
luciferase reporter plasmid pRL-TK (Stratagene, La Jolla, CA, USA), to control for 
transfection efficiency using a FuGENE 6 transfection reagent (Roche, Indianapolis, IN, 
USA). At 24 h after the start of transfection, cells were incubated with LPS (100 ng/ml) in 
the presence or absence of the extracts for 24 h. Luciferase activity in the cell lysate was 
measured using a Dual-Luciferase Reporter Assay Kit (Promega) and a FLUOstar Optima 
(BMG Labtech, Offenburg, Germany). Luciferase activity was normalized to transfection 
efficiency, as monitored using a Renilla luciferase expression vector. The level of induced 
luciferase activity was determined as a ratio to the luciferase activity of unstimulated cells. 
2.11 Statistical analysis  
All experiments were conducted in triplicate, but only data from one representative trial are 
presented. Results are expressed as the mean ± standard deviation (SD). Treatment effects 
were analyzed using a paired t-test. 
3. Results 
3.1 Antioxidant activities of S. quelpaertensis leaf extracts 
Table 2 summarizes the antioxidant activities of S. quelpaertensis leaf methanol extract and its 
fractions, represented by IC50. The IC50 values for DPPH radical scavenging activity against 
MeOH extract, EtOAc, and BuOH fractions were 862.5, 288.9, and 166.4 μg/ml, respectively. 
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DPPH radical scavenging activity of the BuOH fraction was more potent than that of other 
tested samples. For NO scavenging activity, the IC50 value (259.4 μg/ml) was calculated 
only for the EtOAc fraction; other tested samples exhibited minimal NO scavenging activity. 
All tested samples (except the water fraction) exhibited XOD-inhibition activity and 
superoxide radical scavenging activity. XOD-inhibition activity occurred in the following 
(decreasing) order: EtOAc fraction > hexane fraction > MeOH extract > BuOH fraction. 
Superoxide radical scavenging activity occurred in the following (decreasing) order: EtOAc 
fraction > BuOH fraction > hexane fraction > MeOH extract > water fraction. The IC50 values 
for the EtOAc fraction on XOD-inhibition activity and superoxide radical scavenging 
activity assay were 32.4 and 21.9 μg/ml, respectively. As shown in Table 2, overall 
antioxidant activity was more potent in the EtOAc fraction than in any other tested samples.  
 
Sample 













Methanol extract 862.5 ± 6.4 * 352.9 ± 16.0 113.5 ± 13.4 
Hexane fraction * * 238.4 ± 5.6 62.8 ± 4.3 
EtOAc fraction 288.9 ± 12.7 259.4 ± 1.6 32.4 ± 1.6 21.9 ± 5.4 
BuOH fraction 166.4 ± 9.4 * 473.5 ± 15.4 23.4 ± 5.9 
Water fraction * * - 305.2 ± 6.9 
Trolox 3.49 ± 0.3 * 220.3 ± 12.3 32.5 ± 1.9 
BHA b) 7.6 ± 0.2 * 801.7 ± 11.7 * 
Allopurinol N/A N/A 1.33 ± 0.1 5.1 ± 0.1 
SOD c) N/A N/A * 4.9 ± 1.9 
a) IC50 values were calculated from regression lines using five different concentrations in triplicate 
experiments. 
b) Butylated hydroxyl anisole 
c) Superoxide dismutase 
N/A: Not assay 
* : Can’t calculate the value of IC50 
- : < 5% xanthine oxidase inhibitory activity at maximum concentration used for assay. 
Table 2. Antioxidant activities of the methanol extract and its various fractions from Sasa 
quelplaertensis leaf. 
 
Sample TC50a) (g/ml) IC50b) (g/ml) Selectivity indexc) 
MeOH extract >2000 1341.7  4.9 >1.8 
Hexane fraction 240.1  19.8 175.0  9.6 1.4 
EtOAc fraction 465.2  10.2 68.6  0.1 6.8 
BuOH fraction >2000 >2000 - 
Water fraction >2000 >2000 - 
a) TC50 is the concentration producing 50% toxicity in RAW 264.7 cells. 
b) IC50 is the concentration producing 50% inhibition of NO production in RAW 264.7 cells. 
c) Selectivity Index = TC50 / IC50. 
Table 3. Cell toxicity and the effects of the methanol extract and its fractions of Sasa 
quelpaetensis on LPS-induced NO production in RAW 264.7 cells. 
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Next, we compared the effects of S. quelpaertensis leaf extract on LPS-induced NO 
production in RAW 264.7 cells (see Table 3). Among the tested samples, the EtOAc fraction 
had the highest selectivity index (6.8), indicating it had potent anti-inflammatory properties. 
Thus, we focused on the anti-inflammatory effects of the EtOAc fraction using LPS-
stimulated RAW 264.7 cells.  
3.2 EtOAc fraction inhibits NO production and iNOS expression 
The effects of the EtOAc fraction on NO production in LPS-stimulated RAW 264.7 cells were 
investigated by measuring the amount of nitrite released into the culture medium using a 
 
Fig. 1. Effect of EtOAc fraction on the NO production, iNOS protein and iNOS mRNA 
expression level in LPS-stimulated RAW 264.7 cells. (A) Cells were treated with LPS (100 
ng/ml) alone or LPS plus the indicated concentrations of EtOAc fraction for 24 h. *** P < 
0.001 vs LPS alone-treated cells. Data are expressed in area density as the mean  SD for 
three independent experiments. (B) Cells were treated with LPS (100 ng/ml) alone or LPS 
plus the indicated concentrations (g/ml) of EtOAc fraction for 24 h. (C) Cells were co-
treated with LPS (100 ng/ml) or LPS with EtOAc fraction at the indicated concentration for 
6h. Total RNA was subjected to RT-PCR.  
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Griess reagent system. As shown in Fig. 1A, NO levels increased remarkably with LPS, up 
to 30 μM, but co-treatment with the EtOAc fraction significantly decreased NO levels in a 
dose-dependent manner. In addition, the EtOAc fraction did not affect the viability of RAW 
264.7 cells at concentrations from 32 to 250 μg/ml.  
To investigate whether the inhibition of NO production by the EtOAc fraction was a result 
of inhibition of the corresponding gene expression, we analyzed the expression of iNOS 
protein and mRNA using Western blotting and RT-PCR. LPS increased the levels of cellular 
iNOS protein and mRNA at 24 h and 6 h after treatment, respectively. However, co-
treatment of the EtOAc fraction (32, 63, 125 and 250 μg/ml) with LPS decreased both LPS-
induced protein (Fig. 1B) and iNOS mRNA (Fig. 1C) in a dose-dependent manner. 
We also measured iNOS enzymic activity to investigate whether the EtOAc fraction affected 
enzymatic activity. As shown in Fig. 2, EtOAc treatment (32, 63, 125 and 250 μg/ml) did not 
affect iNOS protein enzyme activity. However, iNOS enzyme activity was inhibited by 1400 
W, which was used as the positive control (data not shown). These results confirmed that 
the EtOAc fraction inhibited NO production in LPS-stimulated RAW 264.7 cells through the 
regulation of iNOS gene expression. 
 
Fig. 2. Effect of EtOAc fraction on iNOS enzyme activity. The iNOS activity was measured 
as using L-arginine as substrate and NADPH-dependent generation of nitrite, the stable 
oxidation products of NO. The assay was performed by incubating with 200 µg of the 
cytosol protein from LPS-stimulated cells, in the absence or presence of EtOAc fraction, for 
180 min at room temperature in 200 µl reaction buffer containing 20 mM Tris–HCl, pH 8.0, 
2 mM NADPH, 2 mM L-arginine, 10 µM FAD. NO3- was reduced to NO2- by incubation at 
37°C for 15 min with 0.1 U/ml nitrate reductase, 0.1 mM NADPH, 5 µM FAD. 
3.3 EtOAc fraction inhibits PGE2 production and COX-2 expression 
PGE2 is the major metabolite produced by COX-2 at inflammation sites. Therefore, we 
examined the effects of the EtOAc fraction on PGE2 production and COX-2 expression. PGE2 
production increased remarkably with LPS (7,800 pg/ml), but co-treatment with the EtOAc 
fraction significantly decreased PGE2 production in a dose-dependent manner (Fig. 3A).  
To investigate whether the inhibition of PGE2 production by the EtOAc fraction was due to 
inhibition of the corresponding gene expression, we analyzed the expression of COX-2 
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protein and mRNA using Western blotting and RT-PCR. As shown in Fig. 3B, COX-2 
protein levels increased in response to LPS treatment, but co-treatment of the EtOAc fraction 
(32, 63, 125 and 250 μg/ml) with LPS decreased COX-2 protein levels in a dose-dependent 
manner. In addition, RT-PCR analysis revealed that the expression of COX-2 mRNA was 
correlated with its protein levels (Fig. 3C). These results indicate that the inhibitory effect of 
the EtOAc fraction on PGE2 production involved regulation of COX-2 gene expression. 
 
Fig. 3. Effect of EtOAc fraction on the PGE2 production, COX-2 protein and mRNA 
expression level in LPS-stimulated RAW 264.7 cells. (A) Cells were treated with LPS (100 
ng/ml) alone or LPS plus the indicated concentrations of EtOAc fraction for 24 h. *** P < 
0.001 vs LPS alone-treated cells. Data are expressed in area density as the mean  SD for 
three independent experiments. (B) Cells were treated with LPS (100 ng/ml) alone or LPS 
plus the indicated concentrations (g/ml) of EtOAc fraction for 24 h. (C) Cells were co-
treated with LPS(100 ng/ml) or LPS with EtOAc fraction at the indicated concentration for 6 
h. Total RNA was subjected to RT-PCR.  
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3.4 EtOAc fraction inhibits pro-inflammatory cytokine mRNA expression 
Pro-inflammatory cytokines, such as IL-1ǃ, IL-6, and TNF-ǂ, are known to affect LPS-
induced macrophage activation during immune responses. Therefore, we investigated the 
effects of the EtOAc fraction on the expression of TNF-ǂ, IL-1ǃ, and IL-6 mRNA in LPS-
stimulated RAW 264.7 cells using RT-PCR analysis. The mRNA levels of these cytokines 
increased at 6 h (IL-1ǃ and IL-6) or 4 h (TNF-ǂ) after LPS treatment. However, co-treatment 
with the indicated concentrations of EtOAc fraction significantly decreased LPS-induced 
TNF-ǂ, IL-1ǃ, and IL-6 mRNA levels in a dose-dependent manner (Fig. 4); at a EtOAc 
fraction concentration of 125 μg/ml, mRNA levels of IL-1ǃ, IL-6, and TNF-ǂ decreased by 
55%, 60%, and 45%, respectively (Fig. 4B). 
 
Fig. 4. Effect of EtOAc fraction on TNF-, IL-1 and IL-6 mRNAs expression level in LPS-
stimulated RAW 264.7 cells. (A) RT-PCR analysis of TNF-, IL-1and IL-6 mRNA 
expression using total RNA extracted RAW 264.7 macrophages stimulated with LPS (100 
ng/ml) alone or LPS plus the indicated concentrations (g/ml) of EtOAc fraction for 6 h 
(TNF- for 4h). (B) Quantification of TNF-, IL-1ǃ, and IL-6 mRNA expression was 
performed by densitometric analysis of the RT-PCR products. The relative level was 
calculated as the ratio of pro-inflammatory mRNA expression to -actin mRNA expression. 
*** P < 0.001, ** P < 0.01 vs LPS alone-treated cells. 
3.5 EtOAc fraction suppresses NF-κB transcriptional activation  
NF-κB regulated the expression of pro-inflammatory cytokines, iNOS, and COX-2. 
Therefore, we investigated the effect of the EtOAc fraction on NF-B activation using a 
transient transfection assay with a NF-B-promoted luciferase reporter gene plasmid (pNF-
B-Luc) in RAW 264.7 cells. The treatment group of EtOAc fraction alone exhibited activity 
similar to the unstimulated control group, confirming that the EtOAc fraction had no effect 
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on NF-B activation in the cells. However, LPS treatment (100 ng/ml, 24 h) increased 
luciferase activity 12-fold compared to the unstimulated control group. The EtOAc fraction 
significantly decreased LPS-induced luciferase activity in a dose-dependent manner (Fig. 5). 
At a concentration of 125 μg/ml, the EtOAc fraction decreased luciferase activity by 
approximately 70% compared to the LPS-stimulated control group. This finding suggests 
that the EtOAc fraction exerts anti-inflammatory effects by suppressing the NF-B activation 
pathway.  
 
Fig. 5. Effect of EtOAc fraction on LPS-induced NF-B transcriptional activation. Cells were 
treated with LPS (100 ng/ml) alone or LPS plus the indicated concentrations (μg/ml) of 
EtOAc fraction for 24 h. NF-B activation detected by luciferase reporter assays. 
*** P < 0.001 vs LPS alone-treated cells. 
 
Fig. 6. Effect of EtOAc fraction on the phosphorylation of ERK1/2, p38, and JNK in LPS-
stimulated RAW 264.7 cells. Cells were treated with LPS (100 ng/ml) alone or LPS plus the 
indicated concentrations (g/ml) of EtOAc fraction for 30 min or 24 h. The protein levels 
were determined by Western blotting. 
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3.6 EtOAc fraction suppresses the phosphorylation of ERK1/2  
Because some MAPKs are known to be stimulated by inflammatory mediators, we also 
investigated how the EtOAc fraction affected three MAPKs (ERK1/2, JNK1/2, and p38 
MAPK) in LPS-stimulated RAW 264.7 macrophages. The phosphorylations of these three 
kinases were detected after cells were subjected to 30 min of LPS treatment. The activation 
of the three MAPKs by LPS treatment did not decrease with co-treatment of the EtOAc 
fraction, but the EtOAc fraction suppressed the phosphorylation of ERK1/2 at 24 h after LPS 
treatment (Fig. 6).  
4. Discussion 
In the human body, oxidative stress is associated with many diseases. Therefore, researchers 
are currently intensely focused on identifying antioxidant agents in plants that may protect 
against oxidative stress, including the Sasa species already used in alternative medicines 
(Jensen et al., 2008; Nakajima et al., 2003; Sood et al., 2009). This study evaluated the 
potential of using S. quelpaertensis leaf in nutraceuticals. As the first step toward identifying 
phytochemicals with beneficial health effects from S. quelpaertensis leaf extracts, we 
evaluated in vitro antioxidant capacities such as DPPH radical scavenging activity, NO 
scavenging activity, XOD-inhibitory activity, and superoxide radical scavenging activity.  
Among the various fractions, the n-butanol soluble fraction exhibited the strongest DPPH 
radical scavenging activity (IC50 = 166.4 μg/ml). This result was consistent with the results 
of Park et al. (2007), who also found significant DPPH radical scavenging activity in the n-
butanol soluble fraction among n-hexane, EtOAc, and aqueous extracts from S. borealis. 
However, the EtOAc fraction was the most potent in nitric oxide scavenging activity (IC50 = 
259.4 μg/ml), superoxide scavenging activity (IC50 = 21.9 μg/ml), and xanthine oxidase 
inhibitory activity (IC50 = 32.4 μg/ml), suggesting its potential as an antioxidant agent.  
Antioxidants such as vitamins C reportedly exhibit anti-inflammatory activity via 
suppression of NF-κB activation (Calfee-Mason et al., 2002; Muñoz et al., 1997). Therefore, 
we further investigated the anti-inflammatory potential of the EtOAc fraction, which 
exhibited the strongest antioxidant potential among various solvent fractions using the 
RAW 264.7 cell line.  
NO is an essential bio-regulatory molecule within the nervous, immune, and cardiovascular 
systems (Bredt & Snyder, 1990; Gold et al., 1990; Palmer et al., 1987). However, increased 
levels of NO derived from iNOS can result in the formation of peroxynitrite after reaction 
with oxygen free radicals during inflammatory responses (Posadas et al., 2000). In the RAW 
264.7 cell, NO production is closely associated with COX-2 expression (Salveminiet al., 
1995), which produces PGE2 and induces an inflammatory reaction (Bennett et al., 1977a, 
1980b, 1982c; Rigas et al., 1993). iNOS and COX-2 are key enzymes regulating the 
production of NO and PGE2, central mediators of inflammation (Possadas et al., 2000; 
Tsatsanis et al., 2006). 
This study demonstrated that the EtOAc fraction inhibited NO production and iNOS 
expression, but it had no effect on iNOS enzyme activity. Additionally, PGE2 production 
and COX-2 expression were attenuated by the EtOAc fraction in a dose-dependent manner. 
These results suggest that the EtOAc fraction from S. quelpaertensis leaves reduced NO and 
PGE2 production via transcriptional regulation of iNOS and COX-2 genes. 
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Pro-inflammatory cytokines, such as IL-1ǃ, IL-6, and TNF-ǂ, interact with each other 
(Pålsson-McDermott & O'Neill, 2004) and affect LPS-induced macrophage activation during 
immune responses (Conti et al., 2004). Moreover, IL-1ǃ, IL-6, and TNF-ǂ secretion increases 
in patients with some inflammatory diseases, such as ulcerative colitis and Crohn’s disease 
(Reinecker et al., 1993); these cytokines play an important role in particle-induced 
inflammation in the lung (Driscoll, 2000; Mansour & Levitz, 2002; Yucesoy et al., 2002). TNF-
ǂ is the main mediator of the LPS reaction and is involved in innate immune reactions and 
chronic inflammatory reactions (Lee et al., 2003). IL-1ǃ is associated with T-cell activation, B-
cell maturation, and NK cell activation (Delgado et al., 2003). Therefore, effective regulation 
of inflammatory mediators is essential (Driscoll, 2000; Hotamisligil, 2008; Hummasti & 
Hotamisligil, 2010). In this study, the EtOAc fraction significantly decreased LPS-induced 
TNF-ǂ, IL-1ǃ, and IL-6 mRNA levels. This finding suggests that the EtOAc fraction exerts a 
beneficial health effect by inhibiting the production of many inflammatory mediators.  
NF-κB is an inducible eukaryotic transcription factor that can regulate the expression of 
numerous genes involved in proliferation, apoptosis, and the immediate–early steps of 
inflammatory and immune responses (Place et al., 2003). NF-κB activation in response to 
pro-inflammatory stimuli involves the degradation of inhibitor κB (IκB) by the IκB kinase 
(IKK) complex. NF-κB is subsequently released, translocates into the nucleus, and initiates 
expression of pro-inflammatory mediators such as cytokines, chemokines, adhesion 
molecules, iNOS, and COX-2 (Baeuerle & Baltimore, 1996; Hayden & Ghosh, 2004). Most 
anti-inflammatory drugs have been shown to suppress the expression of these genes by 
inhibiting the NF-κB activation pathway (Gilroy et al., 2004). Researchers have recently been 
working to identify an anti-inflammatory agent to suppress the NF-κB activation pathway 
(Le et al., 2009; Reddy & Reddanna, 2009). Thus, an NF-κB inhibitor may be useful in the 
development of therapeutic drugs to control the inflammation associated with human 
diseases in a clinical environment. 
The other major extracellular signal transduction pathway stimulated by inflammatory 
mediators is the MAPK pathway (Guha & Mackman, 2001). Three major MAPK pathways 
are a highly conserved family of protein serine/threonine kinases and include the ERK1/2, 
the c-Jun NH2-terminal kinase (JNK1/2), and the p38 mitogen-activated kinase (p38). These 
kinases can trigger the nuclear accumulation and activity of various transcription factors, 
such as NF-κB, ATF2, Elk1, c-fos, and c-jun, which can modulate cytokine and inflammatory 
mediator expression (Aga et al., 2004; Herlaar & Brown, 1999).  
LPS produces inflammatory mediators by activating the NF-κB and MAPK pathways, and 
then induces inflammation in macrophages (Aga et al., 2004; Guha & Mackman, 2001; 
Zhang & Ghosh, 2000). On the basis of the inhibitory effect of the EtOAc fraction on the 
production of inflammatory mediators such as iNOS, COX-2, IL-1ǃ, IL-6, and TNF-ǂ, we 
examined the effect of the EtOAc fraction on NF-κB and MAPK activation in LPS-stimulated 
RAW 264.7 cells. The EtOAc fraction reduced the transcriptional activities of NF-κB, as well 
as the delayed phosphorylation of the ERK1/2 in LPS-stimulated RAW 264.7 cells. Taken 
together, these results suggest that the EtOAc fraction from S. quelpaertensis leaves exhibited 
at least some anti-inflammatory properties by suppressing NF-κB transcriptional activity 
and delaying ERK1/2 activation in LPS-stimulated RAW 264.7 cells. 
Plants of the genus Sasa are known to biosynthesize various compounds such as 
triterpenoids, flavonoids, phenylpropanoids, and flavonolignans (Lee et al., 2007; Sultana & 
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Lee, 2009). In previous research, we demonstrated that a hot water extract of S. quelpaertensis 
leaves exhibited moderate anti-inflammatory activities in LPS-stimulated RAW 264.7 cells 
(Hwang et al., 2007). An ethanol/water extract of bamboo leaf mainly contains flavones, 
glycosides, phenolic acids, coumarin lactones, anthraquinones, and amino acids (Lu et al., 
2005; Zhang & Ding, 1996). Thus, the moderate anti-inflammatory activity of the hot water 
extract may be due to water-soluble phytochemicals. The EtOAc fraction of S. quelpaertensis 
leaves, which contains mainly lipid-soluble compounds, has exhibited potent anti-
proliferative effects via inducing apoptosis on human leukemia HL-60 cells (Jang et al., 
2008). However, the bioactive compounds contained in the plant have not yet been 
identified (Sultana & Lee, 2010). We confirmed that the EtOAc extract contains various 
compounds, including tricin 7-O-ǃ-D-glucopyranoside, two phenylpropanoids, p-hydroxy 
benzaldehyde, and p-coumaric acid, as we investigated the relationships between various 
compounds and their antioxidant or anti-inflammatory properties.  
5. Conclusion 
As an initial step to evaluate the beneficial health effects of S. quelpaertensis, we investigated 
the antioxidant activity and anti-inflammatory activity of S. quelpaertensis leaf extract. 
Among the various fractions, the n-butanol soluble fraction exhibited the strongest DPPH 
radical scavenging activity (IC50 = 166.4 μg/ml). The EtOAc soluble fraction had the 
strongest inhibitory effect in the NO scavenging activity, superoxide scavenging activity, 
and xanthine oxidase inhibitory activity assay (IC50 values were 259, 21.9, and 32.4 μg/ml, 
respectively). Next, we investigated the anti-inflammatory properties of the EtOAc fraction 
in LPS-stimulated RAW 274.7 cells. The EtOAc fraction inhibited production of NO, PGE2, 
iNOS, and COX-2 in a dose-dependent manner. Additionally, pro-inflammatory cytokines, 
such as IL-1ǃ, IL-6, and TNF-ǂ, decreased after co-treatment with the EtOAc fraction 
compared to the LPS-treated group. These results indicate that the EtOAc fraction exhibits 
anti-inflammatory properties via the inhibition of many inflammatory mediators. Finally, on 
the basis of the inhibitory effect of the EtOAc fraction on inflammatory mediators, we 
examined how the EtOAc fraction affected the LPS-induced activation of the NF-κB and 
MAPK pathways. The EtOAc fraction inhibited the phosphorylation of ERK1/2 and the 
transactivation of NF-B, suggesting that the EtOAc fraction suppresses the production of 
pro-inflammatory mediators via the inhibition of NF-κB transactivation and ERK 1/2 
phosprorylation. Taken together, these results indicate that S. quelpaertensis leaf has potential 
for use as an antioxidant and anti-inflammatory agent. 
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